News & Media Catch up with our latest releases here. Filter Article 44 Podcast 3 Video 25 Article Rob Bennett 22/08/2023 Article Rob Bennett 22/08/2023 Notice of results Read More Article Rob Bennett 27/07/2023 Article Rob Bennett 27/07/2023 Oxford Cannabinoid Technologies Takes Pain Drug into Phase I; Appoints Leading Pain Expert Read More Article Rob Bennett 08/05/2023 Article Rob Bennett 08/05/2023 Valentino Parravicini Presents at the Association of Inhalation Toxicologists Annual Conference Read More Article Rob Bennett 28/04/2023 Article Rob Bennett 28/04/2023 Clinical Biomarkers & CDx Conference Europe 2023 Read More Article Rob Bennett 26/07/2022 Article Rob Bennett 26/07/2022 Oxford Cannabinoid Technologies has good opportunities in both lead products says analyst Read More Article Rob Bennett 20/06/2022 Article Rob Bennett 20/06/2022 Outsourcing in Clinical Trials UK & Ireland 2022 Conference – Dr Valentino Parravicini’s Address Read More Article Rob Bennett 16/05/2022 Article Rob Bennett 16/05/2022 Investor Meet Company Q&A Session Read More Article Rob Bennett 25/04/2022 Article Rob Bennett 25/04/2022 Oxford Cannabinoid Technologies Announces Formation of Scientific Advisory Board to Support Clinical Strategy Read More Article Rob Bennett 31/03/2022 Article Rob Bennett 31/03/2022 Updates on Lead Programme 1 (OCT461201) and Programme 2 (OCT130401) - Trigeminal Neuralgia Clinical Trial Read More Article Rob Bennett 04/03/2022 Article Rob Bennett 04/03/2022 Requisition of General Meeting - Update Read More Article Rob Bennett 18/02/2022 Article Rob Bennett 18/02/2022 Requisition of General Meeting Read More Article Rob Bennett 17/02/2022 Article Rob Bennett 17/02/2022 Notice of Analyst and Investment Presentation - How to Register Read More Article Rob Bennett 18/11/2021 Article Rob Bennett 18/11/2021 Oxford Cannabinoid Technologies in drug development deal with Oxford StemTech Read More Article Rob Bennett 17/11/2021 Article Rob Bennett 17/11/2021 Oxford Cannabinoid Technologies in drug development deal with Oxford StemTech Read More Article Rob Bennett 27/10/2021 Article Rob Bennett 27/10/2021 Posting of Annual Report, Notice of AGM and Form of Proxy Read More Article Rob Bennett 12/10/2021 Article Rob Bennett 12/10/2021 Oxford Cannabinoid Technologies work on treatment for chronic, painful disease Trigeminal Neuralgia Read More Article Rob Bennett 11/10/2021 Article Rob Bennett 11/10/2021 Oxford Cannabinoid Technologies Targets Chronic Pain Condition with Latest Formulation Read More Article Rob Bennett 30/09/2021 Article Rob Bennett 30/09/2021 OCT Explore the Opioid Crisis and Chronic Pain Pandemic in Pharmafocus Magazine Read More Article Rob Bennett 22/09/2021 Article Rob Bennett 22/09/2021 Oxford Cannabinoid Technologies' deal for exclusive access to Canopy Growth's cannabinoid library Read More Article Rob Bennett 24/06/2021 Article Rob Bennett 24/06/2021 Chief Scientific Officer Valentino Parravicini to speak at major cannabinoid-based drugs summit in Boston, Massachusetts Read More Newer Posts Older Posts
Article Rob Bennett 27/07/2023 Article Rob Bennett 27/07/2023 Oxford Cannabinoid Technologies Takes Pain Drug into Phase I; Appoints Leading Pain Expert Read More
Article Rob Bennett 08/05/2023 Article Rob Bennett 08/05/2023 Valentino Parravicini Presents at the Association of Inhalation Toxicologists Annual Conference Read More
Article Rob Bennett 28/04/2023 Article Rob Bennett 28/04/2023 Clinical Biomarkers & CDx Conference Europe 2023 Read More
Article Rob Bennett 26/07/2022 Article Rob Bennett 26/07/2022 Oxford Cannabinoid Technologies has good opportunities in both lead products says analyst Read More
Article Rob Bennett 20/06/2022 Article Rob Bennett 20/06/2022 Outsourcing in Clinical Trials UK & Ireland 2022 Conference – Dr Valentino Parravicini’s Address Read More
Article Rob Bennett 16/05/2022 Article Rob Bennett 16/05/2022 Investor Meet Company Q&A Session Read More
Article Rob Bennett 25/04/2022 Article Rob Bennett 25/04/2022 Oxford Cannabinoid Technologies Announces Formation of Scientific Advisory Board to Support Clinical Strategy Read More
Article Rob Bennett 31/03/2022 Article Rob Bennett 31/03/2022 Updates on Lead Programme 1 (OCT461201) and Programme 2 (OCT130401) - Trigeminal Neuralgia Clinical Trial Read More
Article Rob Bennett 04/03/2022 Article Rob Bennett 04/03/2022 Requisition of General Meeting - Update Read More
Article Rob Bennett 18/02/2022 Article Rob Bennett 18/02/2022 Requisition of General Meeting Read More
Article Rob Bennett 17/02/2022 Article Rob Bennett 17/02/2022 Notice of Analyst and Investment Presentation - How to Register Read More
Article Rob Bennett 18/11/2021 Article Rob Bennett 18/11/2021 Oxford Cannabinoid Technologies in drug development deal with Oxford StemTech Read More
Article Rob Bennett 17/11/2021 Article Rob Bennett 17/11/2021 Oxford Cannabinoid Technologies in drug development deal with Oxford StemTech Read More
Article Rob Bennett 27/10/2021 Article Rob Bennett 27/10/2021 Posting of Annual Report, Notice of AGM and Form of Proxy Read More
Article Rob Bennett 12/10/2021 Article Rob Bennett 12/10/2021 Oxford Cannabinoid Technologies work on treatment for chronic, painful disease Trigeminal Neuralgia Read More
Article Rob Bennett 11/10/2021 Article Rob Bennett 11/10/2021 Oxford Cannabinoid Technologies Targets Chronic Pain Condition with Latest Formulation Read More
Article Rob Bennett 30/09/2021 Article Rob Bennett 30/09/2021 OCT Explore the Opioid Crisis and Chronic Pain Pandemic in Pharmafocus Magazine Read More
Article Rob Bennett 22/09/2021 Article Rob Bennett 22/09/2021 Oxford Cannabinoid Technologies' deal for exclusive access to Canopy Growth's cannabinoid library Read More
Article Rob Bennett 24/06/2021 Article Rob Bennett 24/06/2021 Chief Scientific Officer Valentino Parravicini to speak at major cannabinoid-based drugs summit in Boston, Massachusetts Read More